Kolexia
Thomas Marina Médecine générale
Thomas Marina
Médecine générale
Ehpad La Commanderie Des Hospitaliers
Enghien-les-Bains, France
28 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Tumeurs cutanées Toxidermies Lymphome T Lymphome T cutané Micrométastase tumorale Éruptions acnéiformes Tumeurs de la thyroïde Tumeurs du côlon

Collaborateurs

Voir plus
Robert Caroline
Robert Caroline
Gustave-Roussy, Villejuif, France
Routier Emilie
Routier Emilie
Gustave-Roussy, Villejuif, France
Boussemart Lise
Boussemart Lise
Hôpital Hôtel-Dieu Nantes, Nantes, France
Mateus Christine
Mateus Christine
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Amgen
3 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Fixed drug eruption: a monocenter clinical and histological study of 73 cases
Abstracts from the 8th Drug Hypersensitivity Meeting (DHM)    21 août 2018
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.
JAMA dermatology   19 mai 2016
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF Heterodimerization.
Cancer research   29 janvier 2016
Metastatic melanoma: New paradigms of treatment and new toxicities.
EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]   28 juillet 2015
MAP-kinase pathway up or down? Just look at the skin of your patients!
Melanoma research   21 mai 2015
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier.
Journal of cutaneous pathology   23 décembre 2014
Abstract 934: BRAF inhibitors induce skin and extra-cutaneous tumors via paradoxical activation of the MAPK pathway: Molecular study of 66 tumors and visualization of BRAF/CRAF protein dimers
AACR Annual Meeting 2014   01 octobre 2014
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Nature   27 juillet 2014
Detection of residual microscopic disease in melanoma: interest of the sentinel lymph node procedure?.
Bulletin du cancer   11 juin 2014
Kidney injuries related to ipilimumab.
Investigational new drugs   01 avril 2014